Physician profile
Robert Leonardo Plummer
NPI 1508945148
$2,719.84
in general payments reported to CMS, 2019-2025
21 companies · $664 in 2025
The $664 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $141 · 2021: $63.63 · 2022: $280 · 2023: $300 · 2024: $1,013 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,977.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $777.60 | 2023-2025 | Sonicision, Nellcor, Endurant Iis |
| Davol INC. | $473.11 | 2019-2024 | Phasix Mesh, Arista Ah Flexitip |
| Kerecis Limited | $379.46 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ethicon US, LLC | $282.48 | 2023-2025 | Dermabond, Harmonic, Enseal |
| W. L. Gore & Associates, INC. | $120.23 | 2019 | |
| Avanos Medical | $93.19 | 2020 | |
| Solventum Corporation | $80.93 | 2024-2025 | Activ.A.C., V.A.C.Ulta, V.A.C. Veraflo |
| Smith+Nephew, INC. | $67.45 | 2019-2025 | Collagenase Santyl |
| Kci USA, INC. | $63.63 | 2021 | |
| Tela Bio, INC. | $57.42 | 2019 | |
| Organogenesis INC. | $48.77 | 2023 | Puraply |
| Cook Medical LLC | $47.94 | 2025 | Zenith Spiral-Z |
| Convatec INC. | $39.05 | 2024 | |
| Integra Lifesciences Corporation | $29.67 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Covidien Lp | $29.63 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $28.27 | 2025 | Symphony Catheter |
| Octapharma USA, INC. | $27.21 | 2025 | Fibryga |
| Cordis US Corp. | $21.55 | 2025 | Mynx Control Venous |
| Takeda Pharmaceuticals U.S.A., INC. | $19.57 | 2025 | Gattex |
| Innovation Technologies INC | $16.88 | 2020 | |
| Advanced Oxygen Therapy INC. | $15.80 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Plummer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.